These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Glading A, Koziol JA, Krueger J, Ginsberg MH. Cancer Res; 2007 Feb 15; 67(4):1536-44. PubMed ID: 17308092 [Abstract] [Full Text] [Related]
4. Basal caspase activity promotes migration and invasiveness in glioblastoma cells. Gdynia G, Grund K, Eckert A, Böck BC, Funke B, Macher-Goeppinger S, Sieber S, Herold-Mende C, Wiestler B, Wiestler OD, Roth W. Mol Cancer Res; 2007 Dec 15; 5(12):1232-40. PubMed ID: 18171980 [Abstract] [Full Text] [Related]
5. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells. Rosenzweig T, Ziv-Av A, Xiang C, Lu W, Cazacu S, Taler D, Miller CG, Reich R, Shoshan Y, Anikster Y, Kazimirsky G, Sarid R, Brodie C. Cancer Res; 2006 Apr 15; 66(8):4139-48. PubMed ID: 16618735 [Abstract] [Full Text] [Related]
6. The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas. Funke V, Lehmann-Koch J, Bickeböller M, Benner A, Tagscherer KE, Grund K, Pfeifer M, Herpel E, Schirmacher P, Chang-Claude J, Brenner H, Hoffmeister M, Roth W. Cancer Lett; 2013 Jul 28; 335(2):431-40. PubMed ID: 23481023 [Abstract] [Full Text] [Related]
7. MAP kinase pathways involved in glioblastoma response to erucylphosphocholine. Kugler W, Erdlenbruch B, Otten K, Jendrossek V, Eibl H, Lakomek M. Int J Oncol; 2004 Dec 28; 25(6):1721-7. PubMed ID: 15547710 [Abstract] [Full Text] [Related]
8. PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells. Zanca C, Cozzolino F, Quintavalle C, Di Costanzo S, Ricci-Vitiani L, Santoriello M, Monti M, Pucci P, Condorelli G. J Cell Physiol; 2010 Oct 28; 225(1):63-72. PubMed ID: 20648624 [Abstract] [Full Text] [Related]
9. The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling. Anjum R, Roux PP, Ballif BA, Gygi SP, Blenis J. Curr Biol; 2005 Oct 11; 15(19):1762-7. PubMed ID: 16213824 [Abstract] [Full Text] [Related]
10. Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pathways involved in neuroplasticity. Ramos-Miguel A, García-Fuster MJ, Callado LF, La Harpe R, Meana JJ, García-Sevilla JA. Neuroscience; 2009 Jun 16; 161(1):23-38. PubMed ID: 19303913 [Abstract] [Full Text] [Related]
11. Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin. Cui H, Darmanin S, Natsuisaka M, Kondo T, Asaka M, Shindoh M, Higashino F, Hamuro J, Okada F, Kobayashi M, Nakagawa K, Koide H, Kobayashi M. Cancer Res; 2007 Apr 01; 67(7):3345-55. PubMed ID: 17409444 [Abstract] [Full Text] [Related]
12. Constitutive activation of extracellular signal-regulated kinase predisposes diffuse large B-cell lymphoma cell lines to CD40-mediated cell death. Hollmann CA, Owens T, Nalbantoglu J, Hudson TJ, Sladek R. Cancer Res; 2006 Apr 01; 66(7):3550-7. PubMed ID: 16585179 [Abstract] [Full Text] [Related]
13. A death-promoting role for extracellular signal-regulated kinase. Zhuang S, Schnellmann RG. J Pharmacol Exp Ther; 2006 Dec 01; 319(3):991-7. PubMed ID: 16801453 [Abstract] [Full Text] [Related]
14. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Caja L, Sancho P, Bertran E, Iglesias-Serret D, Gil J, Fabregat I. Cancer Res; 2009 Oct 01; 69(19):7595-602. PubMed ID: 19773433 [Abstract] [Full Text] [Related]
15. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M. Anticancer Res; 2009 Jan 01; 29(1):119-23. PubMed ID: 19331140 [Abstract] [Full Text] [Related]
16. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Charest A, Wilker EW, McLaughlin ME, Lane K, Gowda R, Coven S, McMahon K, Kovach S, Feng Y, Yaffe MB, Jacks T, Housman D. Cancer Res; 2006 Aug 01; 66(15):7473-81. PubMed ID: 16885344 [Abstract] [Full Text] [Related]
17. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F. Mol Cancer Res; 2008 Jan 01; 6(1):42-52. PubMed ID: 18234961 [Abstract] [Full Text] [Related]
18. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Opel D, Westhoff MA, Bender A, Braun V, Debatin KM, Fulda S. Cancer Res; 2008 Aug 01; 68(15):6271-80. PubMed ID: 18676851 [Abstract] [Full Text] [Related]
19. Humanin delays apoptosis in K562 cells by downregulation of P38 MAP kinase. Wang D, Li H, Yuan H, Zheng M, Bai C, Chen L, Pei X. Apoptosis; 2005 Oct 01; 10(5):963-71. PubMed ID: 16151632 [Abstract] [Full Text] [Related]
20. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Cui J, Han SY, Wang C, Su W, Harshyne L, Holgado-Madruga M, Wong AJ. Cancer Res; 2006 Oct 15; 66(20):10024-31. PubMed ID: 17047065 [Abstract] [Full Text] [Related] Page: [Next] [New Search]